Literature DB >> 32030297

Accelerating the development of therapeutic strategy for oligometastasis.

Yoshihisa Shimada1.   

Abstract

Year:  2019        PMID： 32030297      PMCID： PMC6987990          DOI： 10.21037/jtd.2019.12.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

Review 2.  Karnofsky Memorial Lecture. Natural history of small breast cancers.

Authors:  S Hellman
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

3.  Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.

Authors:  Maria Teresa Congedo; Alfredo Cesario; Filippo Lococo; Chiara De Waure; Giovanni Apolone; Elisa Meacci; Sergio Cavuto; Pierluigi Granone
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-17       Impact factor: 5.209

4.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

5.  Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.

Authors:  Katelyn K Johnson; Joshua E Rosen; Michelle C Salazar; Daniel J Boffa
Journal:  Ann Thorac Surg       Date:  2016-06-23       Impact factor: 4.330

6.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

7.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.

Authors:  David S Ettinger; Dara L Aisner; Douglas E Wood; Wallace Akerley; Jessica Bauman; Joe Y Chang; Lucian R Chirieac; Thomas A D'Amico; Thomas J Dilling; Michael Dobelbower; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Sandip P Patel; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2018-07       Impact factor: 11.908

8.  Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Authors:  Piet Ost; Dries Reynders; Karel Decaestecker; Valérie Fonteyne; Nicolaas Lumen; Aurélie De Bruycker; Bieke Lambert; Louke Delrue; Renée Bultijnck; Tom Claeys; Els Goetghebeur; Geert Villeirs; Kathia De Man; Filip Ameye; Ignace Billiet; Steven Joniau; Friedl Vanhaverbeke; Gert De Meerleer
Journal:  J Clin Oncol       Date:  2017-12-14       Impact factor: 44.544

Review 9.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.

Authors:  Tawee Tanvetyanon; Lary A Robinson; Michael J Schell; Vivian E Strong; Rachna Kapoor; Daniel G Coit; Gerold Bepler
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

Review 10.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

Authors:  Wilfried E E Eberhardt; Alan Mitchell; John Crowley; Haruhiko Kondo; Young Tae Kim; Andrew Turrisi; Peter Goldstraw; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609
View more
  1 in total

1.  Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.

Authors:  Dung-Tsa Chen; Wenyaw Chan; Zachary J Thompson; Ram Thapa; Amer A Beg; Andreas N Saltos; Alberto A Chiappori; Jhanelle E Gray; Eric B Haura; Trevor A Rose; Ben Creelan
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.